Yamila Rocca

Altered phenotype in peripheral blood and tumor-associated NK cells from colorectal cancer patients

Yamila Rocca, María P. Roberti, Juan Martín Arriaga et al. · Innate Immunity · 2012 · 133 citations

Immunology, Immune Regulation, Pathology +24

Phenotypic and Functional Dysregulated Blood NK Cells in Colorectal Cancer Patients Can Be Activated by Cetuximab Plus IL-2 or IL-15

Yamila Rocca, María Paula Roberti, Estefanía P. Juliá et al. · Frontiers in Immunology · 2016 · 92 citations · Full text

Immunology, Immune Regulation, Pathology +21

IL-2- or IL-15-activated NK cells enhance Cetuximab-mediated activity against triple-negative breast cancer in xenografts and in breast cancer patients

María P. Roberti, Yamila Rocca, Mora Amat et al. · Breast Cancer Research and Treatment · 2012 · 52 citations

Il-15-activated Nk Cells, Breast Oncology, Cancer Immunosurveillance +8

Overexpression of CD85j in TNBC patients inhibits Cetuximab‐mediated NK‐cell ADCC but can be restored with CD85j functional blockade

María P. Roberti, Estefanía P. Juliá, Yamila Rocca et al. · European Journal of Immunology · 2015 · 49 citations · Full text

IL-15 and IL-2 increase Cetuximab-mediated cellular cytotoxicity against triple negative breast cancer cell lines expressing EGFR

María P. Roberti, M. M. Barrio, Alicia Bravo et al. · Breast Cancer Research and Treatment · 2011 · 49 citations

Cancer Immunosurveillance, Immunology, Immune Checkpoint Inhibitor +4